Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin

American Journal of Physiology - Renal Physiology

Volumn 275, Issue 3 44-3, 1998, Pages

  Lisy, Ondrej ^a   Jougasaki, Michihisa ^a   Schirger, John A ^a   Chen, Horng H ^a   Barclay, Paul T ^a   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Kidney; Metalloprotease inhibitor; Natriuretic peptide; Sodium excretion

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; MEMBRANE METALLOENDOPEPTIDASE; SODIUM ION;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; DOG; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME SUBSTRATE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MALE; NATRIURESIS; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 0031689073     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.275.3.f410     Document Type: Article

References (23)

1. Dussaule, J. C., C. Michel, M. N. Peraldi, J. M. Lecomte, C. Gros, F. Mignon, and R. Ardaillou. Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure. Clin. Sci. (Colch.) 84: 31-39, 1993.
2. Ebara, T., K. Miura, M. Okumura, T. Matsuura, S. Kim, T. Yukimura, and H. Iwao. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur. J. Pharmacol. 263: 69-73, 1994.
3. Eguchi, S., Y. Hirata, H. Kano, K. Sato, Y. Watanabe, T. X. Watanabe, K. Nakajima, S. Sakakibara, and F. Marumo. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett. 340: 226-230, 1994.
4. Hirata, Y., H. Hayakawa, Y. Suzuki, E. Suzuki, H. Ikenouchi, O. Kohmoto, K. Kimura, K. Kitamura, T. Eto, K. Kangawa, H. Matsuo, and M. Omata. Mechanisms of adrenomedullin-induced vasodilatation in the rat kidney. Hypertension 25: 790-795, 1995.
5. Ishizaka, Y., Y. Ishizaka, M. Tanaka, K. Kitamura, K. Kangawa, N. Minamino, H. Matsuo, and T. Eto. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 200: 642-646, 1994.
6. Jougasaki, M., L. L. Aarhus, D. M. Heublein, S. M. Sandberg, and J. C. Burnett, Jr. Role of prostaglandins and renal nerves in the renal actions of adrenomedullin. Am. J. Physiol. 272 (Renal Physiol. 41): F260-F266, 1997.
7. Jougasaki, M., C.-M. Wei, L. L. Aarhus, D. M. Heublein, S. M. Sandberg, and J. C. Burnett, Jr. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F657-F663, 1995.
8. Jougasaki, M., C.-M. Wei, L. J. McKinley, and J. C. Burnett, Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92: 286-289, 1995.
9. Kenny, A. J., and S. L. Stephenson. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett. 232: 1-8, 1988.
10. Kitamura, K., J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194: 720-725, 1993.
11. Lewis, L. K., M. W. Smith, S. O. Brennan, T. G. Yandle, A. M. Richards, and M. G. Nicholls. Degradation of human adrenomedullin (1-52) by plasma membrane enzymes and identification of metabolites. Peptides 18: 733-739, 1997.
12. Lipkin, G. W., A. B. Dawnay, S. M. Harwood, W. R. Cattell, and A. E. Raine. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure. Kidney Int. 52: 792-801, 1997.
13. Majid, D. S., P. J. Kadowitz, D. H. Coy, and L. G. Navar. Renal responses to intra-arterial administration of adrenomedullin in dogs. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F200-F205, 1996.
14. Margulies, K. B., and J. C. Burnett, Jr. Neutral endopeptidase 24.11: a modulator of natriuretic peptides. Semin. Nephrol. 13: 71-77, 1993.
15. Margulies, K. B., P. C. Cavero, A. A. Seymour, N. G. Delaney, and J. C. Burnett, Jr. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int. 38: 67-72, 1990.
16. Nagatomo, Y., K. Kitamura, K. Kangawa, Y. Fujimoto, and T. Eto. Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase. Biochem. Biophys. Res. Commun. 223: 539-543, 1996.
17. Rademaker, M. T., C. J. Charles, E. A. Espiner, M. G. Nicholls, A. M. Richards, and T. Kosoglou. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure. Clin. Sci. (Colch.) 91: 283-291, 1996.
18. Seymour, A. A., M. M. Asaad, V. M. Lanoce, S. A. Fennell, H. S. Cheung, and W. L. Rogers. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure. Cardiovasc. Res. 27: 1015-1023, 1993.
19. Shima, M., Y. Seine, S. Torikay, and M. Imai. Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments. Life Sci. 43: 357-363, 1988.
20. Steiner, A. L., C. W. Parker, and D. M. Kipnis. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 247: 1106-1113, 1972.
21. Szokodi, I., P. Kinnunen, P. Tavi, M. Weckstrom, M. Toth, and H. Ruskoaho. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 97: 1062-1070, 1998.
22. Vari, R. C., S. D. Adkins, and W. K. Samson. Renal effects of adrenomedullin in the rat. Proc. Soc. Exp. Biol. Med. 211: 178-183, 1996.
23. Wegner, M., J. P. Stasch, C. Hirth-Dietrich, J. Dressel, K. P. Voges, and S. Kazda. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs. Clin. Exp. Hypertens. 17: 861-871, 1995.